The iconic rise of Viagra has consistently remained a symbol of pharmaceutical success, but its future within the broader sector now raises questions about long-term yields . Alternative versions are eroding market share, prompting anxieties that supporting companies heavily reliant to Viagra's previous influence could be a speculative decision , e